GLOBAL BONE MARROW TRANSPLANT MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL BONE MARROW TRANSPLANT MARKET FORECAST 2018-2026

GLOBAL BONE MARROW TRANSPLANT MARKET FORECAST 2018-2026

The Global Bone marrow transplant market is anticipated to grow at a CAGR of 5.45% between 2018 and 2026. A bone marrow transplant is a medical procedure, which is performed to replace the damaged or destroyed bone marrow due to infections, disease, or adverse effect of treatment. The Bone marrow transplant market is primarily driven by the following factors:

GLOBAL BONE MARROW TRANSPLANT MARKET FORECAST 2018-2026

Global Bone Marrow Transplant Market by Transplant Type (Autologous Bone Marrow Transplant, Allogeneic Bone Marrow Transplant) by Indication (Multiple Myeloma, Acute Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Solid Tumors & Other) by End User (Multispecialty Clinics, Hospitals, Ambulatory Surgical Centers) by Geography

Request free sample

The Global Bone marrow transplant market is anticipated to grow at a CAGR of 5.45% between 2018 and 2026. A bone marrow transplant is a medical procedure, which is performed to replace the damaged or destroyed bone marrow due to infections, disease, or adverse effect of treatment. The Bone marrow transplant market is primarily driven by the following factors:

  • Increased prevalence of cancer
  • Increase in federal funding for regenerative medicines

Bone Marrow Transplant Market

To learn more about this report, request a free sample copy

The important driver increasing growth in the Global Bone Marrow Transplant Market is the increased prevalence of cancer. The prevalence of cancer is growing rapidly and is expected to grow at higher rates in the future too. For instance, the CDC expects that between 2010 and 2020, the new cancer cases will reach 24% among men and 21% in women, with the incidence rate remaining almost flat.

The Indications of Bone marrow transplant market are used extensively for various purposes. Multiple myeloma is a type of cancer formed by malignant plasma cells, which are found in plasma cells but are vital for the immune system. Acute leukaemia is the malignant transformation of hematopoietic stem cell into a primitive and undifferentiated cell with abnormal functionality. Hodgkin lymphoma is the cancer of lymphatic system, which is a vital part of immune system. Non-Hodgkin lymphoma type of cancer originates from lymphocytes and lymph node tissues, which are the cells of the lymphatic and immune system. Solid tumours may be benign (not cancer), or malignant (cancer). A bone marrow transplant is also used in various other conditions, which contributes a minor share of the overall global bone marrow transplant market.

The scarcity of donors and its genetical acceptance and ethical issues are the major factors hindering the Bone marrow transplant market. The supply and demand for bone marrow transplant are in imbalance, and this is one of the major challenges faced by this market. Also,  ethical issues in bone marrow transplant are considered to be a big hindrance.

The Global Bone marrow transplant market segments include Transplant types, Indications and End users.

Transplant types are segmented into:

  • An autologous bone marrow transplant
  • An allogeneic bone marrow transplant

Indications are segmented into:

  • Multiple myelomas
  • Acute leukaemia
  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Solid tumours
  • Other indication

End users are segmented into:

  • Multispecialty clinics
  • Hospitals
  • Ambulatory surgical centres

This report covers the present market conditions and the growth prospects of the Global Bone Marrow Transplants Market for 2018-2026 and considered the revenue generated through the sales of Bone marrow transplants for Transplant types, Indications and End users to calculate the market size by considering 2017 as the base year.

Geographically, the Global Bone Marrow Transplants Market has been segmented on the basis of four major regions, which includes:

  • North America: The U.S. & Canada
  • Asia-Pacific: China, India, Japan, South Korea & Rest of APAC
  • Europe: The UK, France, Germany, Spain, Italy & Rest of Europe
  • Rest of World: Latin America & Middle East and Africa

The Bone marrow transplant market in Europe is expected to hold the largest share of 2026 owing to the increased prevalence of cancer in Europe, especially colorectal cancer, prostate cancer in males and breast cancer in females. Proactive government policies by various governments such as Spain, United Kingdom etc. also drives the bone marrow transplant market. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the Bone marrow transplant market. Asia-Pacific bone marrow transplant market is the fastest growing geography in the global scenario. The growing population in countries such as China and India, rising investments by public and private sectors in the cancer diagnosis and treatment as well as the growing prevalence rate of cancer in the Asia-pacific geography are acting as primary drivers for the development and expansion of Bone marrow transplant market in the Asia-pacific.

The Bone Marrow Transplant Market is segmented on the basis of Transplant types which are sub-divided into allogeneic bone marrow transplant and autologous bone marrow transplant and is also segmented on the basis of End users which are sub-divided into Multispecialty Clinics, Hospitals, and Ambulatory Surgical Centers. In autologous stem cell transplants, the patient is his own stem cell donor. Allogeneic transplant is another type of bone marrow transplant wherein stem cells from a genetically identical donor are used. The primary purpose of a multi-speciality clinic is to serve all the needs of patients in one convenient location. Ambulatory Surgery Centers, known as ASCs, are modern healthcare facilities focused on providing same-day surgical care, including diagnostic and preventive procedures.

The major market players in the Global Bone Marrow Transplant Market are:

  • Abbott Laboratories
  • AgendiaV.
  • Diadexus Inc. (Acquired By Diazyme Laboratories)
  • Qiagen N.V.
  • Sanofi

Company Profiles covers analysis of important players.

Abbott Laboratories (Abbott) is a U.S. based company, headquartered in Illinois. The company discovers, develop, manufactures and sell a line of healthcare products. The company was established in 1888. Sanofi SA (Sanofi or ‘the group’) is a France-based international pharmaceutical group engaged in research, development, manufacture, and marketing of healthcare products.

Key Findings of the Global Bone Marrow Transplant Market:

  • Europe constitutes the largest market share in terms of geography
  • Solid tumours are the fastest growing indication in the bone marrow transplant market
  • Autologous bone marrow transplant type dominates the bone marrow transplant market
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • EUROPE CONSTITUTES THE LARGEST MARKET SHARE IN TERMS OF GEOGRAPHY
      • SOLID TUMORS ARE THE FASTEST GROWING INDICATION IN THE BONE MARROW TRANSPLANT MARKET
      • AUTOLOGOUS BONE MARROW TRANSPLANT TYPE DOMINATES THE BONE MARROW TRANSPLANT MARKET
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • INCREASED PREVALENCE OF CANCER
      • INCREASE IN FEDERAL FUNDING IN REGENERATIVE MEDICINES
    • MARKET RESTRAINTS
      • SCARCITY OF DONORS AND ITS GENETICAL ACCEPTANCE
      • ETHICAL ISSUES
    • MARKET OPPORTUNITIES
      • RISE IN REIMBURSEMENT FOR SURGERIES IN DEVELOPED NATIONS
      • TECHNOLOGICAL INNOVATIONS
    • MARKET CHALLENGES
      • HIGH COST OF TREATMENT
  1. MARKET SEGMENTATION
    • MARKET BY TRANSPLANT TYPE 2018-2026
      • AUTOLOGOUS BONE MARROW TRANSPLANT
      • ALLOGENEIC BONE MARROW TRANSPLANT
    • MARKET BY INDICATION 2018-2026
      • MULTIPLE MYELOMA
      • ACUTE LEUKEMIA
      • HODGKIN LYMPHOMA
      • NON-HODGKIN LYMPHOMA
      • SOLID TUMORS
      • OTHER INDICATION
    • MARKET BY END USER 2018-2026
      • MULTISPECIALTY CLINICS
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF RIVALRY
    • KEY MARKET TRENDS
      • NEWER APPLICATION OF BONE MARROW TRANSPLANT
      • ONLINE SERVICES
    • KEY BUYING CRITERIA
      • HIGH PRICE
      • EFFICACY
      • APPLICATION AND EFFECTIVENESS
      • ACCURACY
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM (UK)
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA (MEA)
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • AFFYMETRIX, INC. (ACQUIRED BY THERMOFISHER)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • AGENDIAV.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • AGILENT TECHNOLOGIES, INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • AMBRILIA BIOPHARMA INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ASTELLAS PHARMA INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • DIADEXUS INC. (ACQUIRED BY DIAZYME LABORATORIES)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ILLUMINA, INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • QIAGEN N.V.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ROCHE DIAGNOSTICS LTD
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • SANOFI
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SWOT ANALYSIS
      • STRATEGIC INITIATIVES
    • STRYKER CORPORATION
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES

 

TABLE LIST

TABLE  1      GLOBAL BONE MARROW MARKET TRANSPLANT MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  2      GLOBAL BONE MARROW TRANSPLANT MARKET BY TRANSPLANT TYPE 2018-2026 ($ MILLION)

TABLE  3      GLOBAL BONE MARROW TRANSPLANT MARKET BY INDICATION 2018-2026 ($ MILLION)

TABLE  4      GLOBAL BONE MARROW TRANSPLANT MARKET IN MULTIPLE MYELOMA BY TRANSPLANT TYPE 2018-2026 ($ MILLION)

TABLE  5      GLOBAL BONE MARROW TRANSPLANT MARKET IN ACUTE LEUKEMIA BY TRANSPLANT TYPE 2018-2026 ($ MILLION)

TABLE  6      GLOBAL BONE MARROW TRANSPLANT MARKET IN HODGKIN LYMPHOMA BY TRANSPLANT TYPE 2018-2026 ($ MILLION)

TABLE  7      GLOBAL BONE MARROW TRANSPLANT MARKET IN NON-HODGKIN LYMPHOMA BY TRANSPLANT TYPE 2018-2026 ($ MILLION)

TABLE  8      GLOBAL BONE MARROW TRANSPLANT MARKET IN SOLID TUMORS BY TRANSPLANT TYPE 2018-2026 ($ MILLION)

TABLE  9      GLOBAL BONE MARROW TRANSPLANT MARKET, BY GEOGRAPHY 2018-2026($ MILLION)

TABLE  10    NORTH AMERICA BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

TABLE  11    EUROPE BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

TABLE  12    ASIA-PACIFIC BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

TABLE  13    REST OF WORLD BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE LIST          

FIGURE  1    BONE MARROW BLOOD COMPONENTS

FIGURE  2    GLOBAL BONE MARROW MARKET TRANSPLANT 2018-2026 ($ MILLION)

FIGURE  3    DIFFERENT TYPES OF CANCERS MANAGED BY BONE MARROW TRANSPLANT

FIGURE  4    ETHICAL ISSUES REQUIREMENTS IN BONE MARROW TRANSPLANT

FIGURE  5    PHASES IN BONE MARROW TRANSPLANT

FIGURE  6    GLOBAL BONE MARROW TRANSPLANT MARKET IN AUTOLOGOUS BONE MARROW TRANSPLANT 2018-2026 ($ MILLION)

FIGURE  7    GLOBAL BONE MARROW TRANSPLANT MARKET IN ALLOGENIC BONE MARROW TRANSPLANT 2018-2026 ($ MILLION)

FIGURE  8    GLOBAL BONE MARROW TRANSPLANT MARKET IN MULTIPLE MYELOMA 2018-2026 ($ MILLION)

FIGURE  9    GLOBAL BONE MARROW TRANSPLANT MARKET IN ACUTE LEUKEMIA 2018-2026 ($ MILLION)

FIGURE  10  GLOBAL BONE MARROW TRANSPLANT MARKET IN HODGKIN LYMPHOMA 2018-2026 ($ MILLION)

FIGURE  11  GLOBAL BONE MARROW TRANSPLANT MARKET IN NON-HODGKIN LYMPHOMA 2018-2026 ($ MILLION)

FIGURE  12  GLOBAL BONE MARROW TRANSPLANT MARKET IN SOLID TUMORS 2018-2026 ($ MILLION)

FIGURE  13  GLOBAL BONE MARROW TRANSPLANT MARKET IN OTHER INDICATION 2018-2026 ($ MILLION)

FIGURE  14  GLOBAL BONE MARROW TRANSPLANT MARKET IN MULTISPECIALTY CLINICS 2018-2026 ($ MILLION)

FIGURE  15  GLOBAL BONE MARROW TRANSPLANT MARKET IN HOSPITALS 2018-2026 ($ MILLION)

FIGURE  16  GLOBAL BONE MARROW TRANSPLANT MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)

FIGURE  17  UNITED STATES BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  18  CANADA BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  19  PERCENTAGE VISE DISTRIBUTION OF VARIOUS CANCERS ENGLAND (2016)

FIGURE  20  THE UNITED KINGDOM BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  21  FRANCE BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  22  GERMANY BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  23  SPAIN BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  24  ITALY BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  25  REST OF EUROPE BIOMARKERS MARKET 2018-2026 ($ MILLION)

FIGURE  26  CHINA BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  27  INDIA BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  28  JAPAN BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  29  SOUTH KOREA BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  30  REST OF ASIA-PACIFIC BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  31  LATIN AMERICA BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

FIGURE  32  MIDDLE EAST AND AFRICA BONE MARROW TRANSPLANT MARKET 2018-2026 ($ MILLION)

  1. MARKET SEGMENTATION
    • MARKET BY TRANSPLANT TYPE 2018-2026
      • AUTOLOGOUS BONE MARROW TRANSPLANT
      • ALLOGENEIC BONE MARROW TRANSPLANT
    • MARKET BY INDICATION 2018-2026
      • MULTIPLE MYELOMA
      • ACUTE LEUKEMIA
      • HODGKIN LYMPHOMA
      • NON-HODGKIN LYMPHOMA
      • SOLID TUMORS
      • OTHER INDICATION
    • MARKET BY END USER 2018-2026
      • MULTISPECIALTY CLINICS
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM (UK)
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA (MEA)

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now